Výsledky vyhledávání - "Kimberly A. Quaid"

Akademický článek

Benchmarks for ethically credible partnerships between industry and academic health centers: beyond disclosure of financial conflicts of interest

Autor: Eric M. Meslin, Joshua B. Rager, Peter H. Schwartz, Kimberly A. Quaid, Margaret M. Gaffney, Jon Duke, William M. Tierney

Publikováno v: Clinical and Translational Medicine, Vol 4, Iss 1, Pp n/a-n/a (2015)

AbstractRelationships between industry and university‐based researchers have been commonplace for decades and have received notable attention concerning the conflicts of interest these relationships may harbor. While new efforts are being made to u

Externí odkaz: https://doaj.org/article/c3f4df1fe0af47d4aad38d55b5d779b5

Zobrazit plný text záznamu

Seizures as an early symptom of autosomal dominant Alzheimer’s disease

Publikováno v: Neurobiology of aging 76, 18-23 (2019). doi:10.1016/j.neurobiolaging.2018.11.022

Our objective was to assess the reported history of seizures in cognitively asymptomatic mutation carriers for autosomal dominant Alzheimer's disease (ADAD) and the predictive value of seizures for mutation carrier status in cognitively asymptomatic

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::955bc2a86643a735efbf2a69929d6d23
https://europepmc.org/articles/PMC6572755/

Zobrazit plný text záznamu

Autor: Ira Shoulson, Elise Kayson-Rubin, Shirley Eberly, Kimberly A. Quaid, David Oakes

Publikováno v: Clinical Genetics. 91:824-831

Huntington disease (HD) is a late onset ultimately fatal neurodegenerative disorder caused by a cytosine-adenine-guanine ( CAG) triplet repeat expansion in the Huntingtin gene which was discovered in 1993. The PHAROS study is a unique observational s

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_________::a47e1b583660d584172c8fc7d05cd5d8
https://doi.org/10.1111/cge.12893

Zobrazit plný text záznamu

HDQLIFE: development and assessment of health-related quality of life in Huntington disease (HD)

Publikováno v: Quality of life research : an international journal of quality of life aspects of treatment, care and rehabilitation, vol 25, iss 10
Carlozzi, NE; Schilling, SG; Lai, J-S; Paulsen, JS; Hahn, EA; Perlmutter, JS; et al.(2016). HDQLIFE: development and assessment of health-related quality of life in Huntington disease (HD). QUALITY OF LIFE RESEARCH, 25(10), 2441-2455. doi: 10.1007/s11136-016-1386-3. UC San Francisco: Retrieved from: http://www.escholarship.org/uc/item/2nb8m503

PurposeHuntington disease (HD) is a chronic, debilitating genetic disease that affects physical, emotional, cognitive, and social health. Existing patient-reported outcomes (PROs) of health-related quality of life (HRQOL) used in HD are neither compr

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::4bbbafa8aae8fa6b2f7e3134af397145
https://doi.org/10.1007/s11136-016-1386-3

Zobrazit plný text záznamu

New measures to capture end of life concerns in Huntington disease: Meaning and Purpose and Concern with Death and Dying from HDQLIFE (a patient-reported outcomes measurement system)

Autor: Stephen G. Schilling, Noelle E. Carlozzi, Michael K. McCormack, Elizabeth A. Hahn, Jennifer A. Miner, Martha Nance, Jin Shei Lai, Samuel Frank, Siera Goodnight, Kimberly A. Quaid, Nancy R. Downing, Jane S. Paulsen, Joel S. Perlmutter, David Cella

Publikováno v: Quality of Life Research. 25:2403-2415

Huntington disease (HD) is an incurable terminal disease. Thus, end of life (EOL) concerns are common in these individuals. A quantitative measure of EOL concerns in HD would enable a better understanding of how these concerns impact health-related q

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::51993e539ea15d5e6921342bfb91ddbe
https://doi.org/10.1007/s11136-016-1354-y

Zobrazit plný text záznamu

The impact of oculomotor functioning on neuropsychological performance in Huntington disease

Autor: William Mallonee, Thomas T. Warner, Vicki L. Wheelock, Emily P. Freney, Stephen M. Rao, Vincent A. Magnotta, Alma Macaraeg, Sigurd D. Süßmuth, Paula Wasserman, Shineeka Smith, Phil Danzer, Anne Elizabeth Rosser, Michael D. Geschwind, Brenton Maxwell, Kelsey Montross, Gabriella Satris, Albie Law, Daniel S. O'Leary, David J. Moser, Thomas Brashers-Krug, Janessa O. Carvalho, Hans J. Johnson, Martha Nance, Anita M.Y. Goh, Mark Guttman, J. Preston, Janet K. Williams, Judith Bek, Susan Perlman, Alanna Sheinberg, Wenjing Lu, Christine Reece, Pietro Mazzoni, Nadine Yoritomo, Elizabeth Aylward, W.R. Wayne Martin, Megan M. Smith, Phyllis Chua, J. Decolongon, Breanna Nickels, Pamela King, Deborah L. Harrington, Roland Zschiegner, Brian Clemente, David G. Gunn, Alex Bura, Vivien Vaughan, Samantha M Loi, Maggie Burrows, Kimberly A. Quaid, Jillian McMillan, Jason Evans, Michael Orth, Mary Wodarski, Courtney Shadrick, Sarah L Mason, H. Jeremy Bockholt, Marguerite Wieler, Elizabeth Howard, Melissa Wesson, Kathy Price, Lisa Kjer, Daniela Rae, Lynn A. Raymond, Roger A. Barker, Edmond Chiu, Holly Westervalt, Joanne Wojcieszek, Stephanie Antonopoulos, Ji In Kim, Jane S. Paulsen, Maryjane Ong, Spencer Lourens, Maria Tedesco, Katrin Barth, Christina Reeves, Jane Griffith, Peter K. Panegyres, Sarah Hunt, Cathy Wood-Siverio, David Craufurd, Holly James Westervelt, Zosia Miedzybrodzka, A. Coleman, Irita Karmalkar, Joseph W. Y. Lee, Carolin Eschenbach, Greg Suter, Christopher A. Ross, Satwinder Sran, Sharon J. Sha, Daniela Schwenk, Joel S. Perlmutter, Ali Samii, James A. Mills, Mark Varvaris, Amanda Miller, Frederick J. Marshall, Amy M. Chesire, Isabella De Soriano, Ying Zhang, Natalie Valle Guzman, Angela Komiti, Oksana Suchowersky, Clement T. Loy, Diane Erickson, Karen Marder, Lyla Mourany, Joseph Winer, Anwar Ahmed, Jatin G. Vaidya, Eun Young Kim, Stacey K. Barton, Cheryl Erwin, Sonja Trautmann, Amanda Martin, Stewart A. Factor, Elizabeth McCusker, Mariella D'Alessandro, Jeffrey D. Long, Randi Jones, Nancy R. Downing, Jared M. Bruce, Charlyne Hickey, Rajeev Kumar, Mannie Fan, Sarah E Tomaszewski Farias

Publikováno v: J Clin Exp Neuropsychol

Huntington disease (HD) is a neurodegenerative condition with prominent motor (including oculomotor), cognitive, and psychiatric effects. While neuropsychological deficits are present in HD, motor impairments may impact performance on neuropsychologi

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::121c69c02b6180b607f78aa69fd80915
https://doi.org/10.1080/13803395.2015.1101054

Zobrazit plný text záznamu

Plný text ve formátu HTML

Relationships among Apathy, Health-Related Quality of Life and Function in Huntington’s disease

Autor: Michael K. McCormack, Susan Perlman, Julie C. Stout, Nicholas R. Boileau, Joel S. Perlmutter, Nora E. Fritz, Kimberly A. Quaid, Rebecca E. Ready, Jane S. Paulsen, Noelle E. Carlozzi, Stacey K. Barton

Up to 90% of individuals with Huntington's disease (HD)-a progressive, inherited neurodegenerative disorder-experience apathy. Apathy is particularly debilitating because it is marked by a reduction in goal-directed behaviors, including self-care, so

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::2ae812c3fc602057d3d07c87705c4fb8
https://europepmc.org/articles/PMC6081241/

Zobrazit plný text záznamu

Clinical use of amyloid‐positron emission tomography neuroimaging: Practical and bioethical considerations

Autor: Michael Wasserman, Monique M. Williams, Helen Hochstetler, Michael J. Pontecorvo, Kimberly A. Quaid, Gail Hunt, Michael M. Witte, James L. Levenson, Gil D. Rabinovici, Luann E. Van Campen, Adam S. Fleisher, Norman L. Foster, J. Scott Roberts, Paula T. Trzepacz, Linda B. Tabas, Ann Marie Hake, Craig A. Hunter

Publikováno v: Alzheimer's & Dementia : Diagnosis, Assessment & Disease Monitoring
Alzheimer’s & Dementia: Diagnosis, Assessment & Disease Monitoring, Vol 1, Iss 3, Pp 358-367 (2015)
Alzheimer's & dementia (Amsterdam, Netherlands), vol 1, iss 3

Until recently, estimation of β‐amyloid plaque density as a key element for identifying Alzheimer's disease (AD) pathology as the cause of cognitive impairment was only possible at autopsy. Now with amyloid‐positron emission tomography (amyloid�

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::373ed924fb3f74cf5224453bbd5b94e5
https://doi.org/10.1016/j.dadm.2015.06.006

Zobrazit plný text záznamu

Vyhledávací nástroje:

Upřesnit hledání